LOS ANGELES--(BUSINESS WIRE)--Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Koninklijke Philips (“Koninklijke” or the “Company”) (NYSE: PHG).
If you purchased or otherwise acquired Koninklijke shares, and would like more information about the investigation, we encourage you to contact Michael Goldberg or Brian Schall, of Goldberg Law PC, 1999 Avenue of the Stars, Suite 1100, Los Angeles, CA 90067, at 800-977-7401, to discuss your rights without cost to you.
The investigation focuses on whether Koninklijke and certain of its officers and/or directors violated federal securities laws. On October 11, 2017, the Company announced that it reached an agreement with the U.S. Department of Justice to temporarily suspend the manufacture and distribution of certain defibrillators for the U.S. market to allow closer inspections and ensure it is in compliance with applicable U.S. Food & Drug Administration regulations. The Company advised investors that production would likely be halted until sometime in 2018 and could reduce earnings before interest, taxes and amortization by nearly 20 million euros in the fourth quarter of 2017, and by an additional 60 million euros in 2018. Following this news, Koninklijke’s stock price dropped.
If you have any questions concerning your legal rights, please immediately contact Goldberg Law PC at 800-977-7401, or visit our website at http://www.Goldberglawpc.com, or email us at email@example.com.
Goldberg Law PC represents investors around the world, and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.